How do stem cells treat degenerative disc disease?

MSCs can regenerate disc tissue by promoting hydration and matrix production within degenerated discs, reducing inflammation, and slowing further degeneration. This provides pain relief and improved spinal function.

Can stem cell therapy avoid the need for spinal surgery?

For many patients with degenerative disc disease, MSC therapy offers a minimally invasive alternative to spinal fusion or disc replacement surgery. It addresses the biological cause of disc degeneration rather than mechanically replacing the disc.

How effective is stem cell therapy for back pain from disc disease?

Clinical studies show 60-80% of patients experience significant pain reduction and improved function after MSC therapy for degenerative disc disease. Results typically appear within 2-4 months.

Stem Cell Therapy for Spinal Cord Injury (2026 Guide)

Research on mesenchymal stem cell treatments for spinal cord injury, covering nerve regeneration, functional recovery, and rehabilitation protocols for SCI patients.

Can Stem Cells Repair Spinal Cord Damage?

Spinal cord injuries (SCIs) result in permanent disability when axons are severed and the lesion site fills with inhibitory glial scar tissue. MSC therapy targets three mechanisms: (1) reducing secondary inflammatory damage that expands the injury zone, (2) releasing neurotrophic growth factors (BDNF, NGF, NT-3) that stimulate axonal regrowth, and (3) promoting remyelination of surviving nerve fibres. Intrathecal delivery (direct injection into cerebrospinal fluid) maximises MSC concentration at the injury site.

Incomplete vs Complete SCI: Who Benefits Most?

Patients with incomplete SCI (some preserved function below the injury level) demonstrate the most consistent benefits — published trials report 1–2 ASIA grade improvements in 40–60% of incomplete injury patients. Complete SCI cases are less responsive, though some patients experience improved sensation, bladder control, or reduced spasticity. Chronic SCI (injury >12 months) also responds, though acute/subacute treatment (within 3–6 months of injury) yields stronger outcomes due to residual tissue plasticity.

Istanbul SCI Treatment Protocol

StemCell Longevita's SCI protocol delivers 100–200 million Wharton's jelly MSCs via combined intrathecal and IV infusion over 3 sessions across 7 days. Treatment is preceded by comprehensive neurological evaluation including MRI and electromyography. Post-treatment rehabilitation support is coordinated with the patient's home physiotherapy team via our 12-month telemedicine programme.

Frequently Asked Questions

How do stem cells treat degenerative disc disease?: MSCs can regenerate disc tissue by promoting hydration and matrix production within degenerated discs, reducing inflammation, and slowing further degeneration. This provides pain relief and improved spinal function.
Can stem cell therapy avoid the need for spinal surgery?: For many patients with degenerative disc disease, MSC therapy offers a minimally invasive alternative to spinal fusion or disc replacement surgery. It addresses the biological cause of disc degeneration rather than mechanically replacing the disc.
How effective is stem cell therapy for back pain from disc disease?: Clinical studies show 60-80% of patients experience significant pain reduction and improved function after MSC therapy for degenerative disc disease. Results typically appear within 2-4 months.

Part of Our Neurological Conditions Content Cluster

Neurological Conditions — Treatment Cluster

Pillar: stem cell therapy for neurological conditions in Istanbul

Research & guides: stem cell therapy for cerebral palsy research | MSC treatment for autism spectrum disorder | stem cell therapy for stroke recovery in Turkey | MSC treatment for spinal cord injury rehabilitation